Khalil Essani is Product Line Manager at Single Use Support. Scientist through and through he develops single-use technologies to further advance the biopharmaceutical industry during its shift towards single-use systems. Based on his extensive expertise and graduate in bioprocessing and biotechnology Khalil authors several publications. At Single Use Support he focuses on sterile products in the field of fluid and cold chain management.
Articles written by Khalil Essani
Drug Delivery
Non-viral vectors vs. viral vectors in gene therapy
When designing gene therapies, the choice between non-viral and viral vectors plays an important role in determining the success and safety of therapeutic interventions. Non-viral vectors offer unique advantages, while viral vectors have their own set of strengths and weaknesses. In this blog post, we will explore the types, benefits, and limitations of both non-viral and viral vectors in gene therapy.
Khalil Essani
September 21, 2023
Drug Delivery
Viral vectors in gene therapy – the function, benefits and risks
Gene therapy holds the promise of revolutionizing medical treatments by harnessing the power of viral vectors to deliver therapeutic genes into the genome of patients. In this blog post, we will illustrate these facets of viral vectors in gene therapy in detail.
Khalil Essani
September 21, 2023
Drug Delivery
Viral vector manufacturing: Production methods & future advances
Viral vector manufacturing involves advanced biotechnological methods, with scalability being one of the major difficulties. In this article, we will discuss both challenges and innovative approaches for viral vector production.
Khalil Essani
September 20, 2023
Drug Delivery
AAV production & efficiency improvements with single-use technology
With adeno-associated virus being a popular viral vector, along with a growing interest in gene therapies, there is an increased need for cost-effective vector manufacturing technologies and viral vector production platforms for human gene therapy products.
Khalil Essani
November 19, 2023
Drug Delivery
Adeno-Associated Virus (AAV) for gene therapy
The adeno-associated virus (AAV) is a very popular viral vector with great potential available for gene delivery. This article explores AAV vectors, their role in gene therapy, and their associated advantages and disadvantages.
Khalil Essani
September 18, 2023
Nucleic Acids
Optimizing pDNA production using advanced single-use technologies
Considering the widespread need for efficient pDNA production, the industry is seeking to improve the current manufacturing process. In this article, we will discover how single-use technologies can contribute to pDNA manufacturing optimizations.
Khalil Essani
November 10, 2023
Bioprocessing
Bioprocessing – everything you need to know
Bioprocessing is a fundamental technology for various aspects of our lives, including the biopharma industry. In this article, we will provide some interesting facts about applications, techniques and future expectations regarding bioprocessing.
Khalil Essani
April 6, 2023
Bioprocessing
Biopharmaceutical processing – how disposable solutions increase safety and efficiency
Biopharmaceutical processing is indispensable across various fields of medicine and life sciences. In this article, we will discover how single-use solutions can increase efficiency and safety in biopharmaceutical processing.
Khalil Essani
November 6, 2023
Biopharma
Fluid management in biopharma: Advantages of single-use systems
Major changes in biopharma industry require new approaches along the supply chain of most innovative biologics – including fluid management. Here's to discover how single-use products help to achieve considerable improvements.
Khalil Essani
November 7, 2023
Bioprocessing
Seed train intensification - the next big step in biopharma?
Seed train intensification is an upstream bioprocessing strategy to improve productivty through modern technologies applying High Cell Density Cryopreservation (HCDC). Learn how seed train intensification can help manufacturers advance production of proteins, such as antibody drug products.
Khalil Essani
November 28, 2024